SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-23-005276
Filing Date
2023-03-31
Accepted
2023-03-31 16:01:50
Documents
103
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K obsa-20221231x10k.htm   iXBRL 10-K 2835834
2 EX-10.20 obsa-20221231xex10d20.htm EX-10.20 123236
3 EX-21.1 obsa-20221231xex21d1.htm EX-21.1 4608
4 EX-31.1 obsa-20221231xex31d1.htm EX-31.1 11450
5 EX-32.1 obsa-20221231xex32d1.htm EX-32.1 5561
6 GRAPHIC obsa-20221231x10k005.jpg GRAPHIC 34391
7 GRAPHIC obsa-20221231x10k006.jpg GRAPHIC 28305
  Complete submission text file 0001558370-23-005276.txt   10820042

Data Files

Seq Description Document Type Size
8 EX-101.SCH obsa-20221231.xsd EX-101.SCH 71056
9 EX-101.CAL obsa-20221231_cal.xml EX-101.CAL 58337
10 EX-101.DEF obsa-20221231_def.xml EX-101.DEF 296060
11 EX-101.LAB obsa-20221231_lab.xml EX-101.LAB 618047
12 EX-101.PRE obsa-20221231_pre.xml EX-101.PRE 527326
97 EXTRACTED XBRL INSTANCE DOCUMENT obsa-20221231x10k_htm.xml XML 1647051
Mailing Address CHEMIN DES AULX, 12 PLAN-LES-OUATES V8 1228
Business Address CHEMIN DES AULX, 12 PLAN-LES-OUATES V8 1228 0041-0-22-552-1558
ObsEva SA (Filer) CIK: 0001685316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37993 | Film No.: 23787398
SIC: 2834 Pharmaceutical Preparations